Tartu University Clinics
Welcome,         Profile    Billing    Logout  
 4 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tronvik, Erling A
MiBlock, NCT04069897: Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine

Recruiting
3
170
Europe
Botulinum toxin type A, botox, Allergan, placebo, sodium chloride
St. Olavs Hospital, Norwegian University of Science and Technology, Oslo University Hospital, Haukeland University Hospital, Nordlandssykehuset HF
Migraine Disorders
12/24
12/24
BASIC, NCT03944876 / 2018-003148-21: Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache

Recruiting
3
112
Europe
Botulinum toxin type A, botox, placebo, Sodium Chloride
Norwegian University of Science and Technology, St. Olavs Hospital, University College, London, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Catholic University of Valencia, PRAXISKLINIK ULMENHOF
Cluster Headache
09/25
09/25
CandMig-3, NCT04574713: Candesartan for Migraine Prevention:

Active, not recruiting
2
450
Europe
Candesartan Oral Tablet 8 mg, Candesartan Oral Tablet 16 mg, Placebo oral tablet
St. Olavs Hospital, Norwegian University of Science and Technology, Nordlandssykehuset HF, Molde Hospital, Haukeland University Hospital, Sorlandet Hospital HF, University Hospital, Akershus, Ullevaal University Hospital, Rikshospitalet University Hospital, University Hospital of North Norway, Tartu University Hospital
Migraine
04/24
10/24
NCT06200480: Nurse Intervention Trial

Recruiting
N/A
400
Europe
Telephone by nurse
Norwegian University of Science and Technology, Haukeland University Hospital, Oslo University Hospital, St. Olavs Hospital
Migraine, Chronic Tension-Type Headache, Cluster Headache, Hemicrania Continua
12/26
12/27
CovaxHEAD, NCT05235776: New-onset Severe Headache After Covid-19 Vaccine

Completed
N/A
63
Europe
observation
Oslo University Hospital, St. Olavs Hospital, University Hospital, Akershus, Vestre Viken Hospital Trust, Hodepineklinikken Bergen, Molde Hospital, Namsos Hospital, Medi3, Oslo Hodepinesenter, Sandvika Nevrosenter
Headache, Migraine, COVID-19
10/23
12/23
Mikkel, Sirje
ALLTogether1, NCT04307576 / 2018-001795-38: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
3
6430
Europe, RoW
Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto
Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins
Leukemia, Acute Lymphoblastic
06/27
06/32
NCT03911128: A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
N/A
500
Europe, RoW
Observational
Mats Heyman, Nordic Society for Pediatric Hematology and Oncology, The Swedish Childhood Cancer Foundation, NordForsk
Leukemia, Acute Lymphoblastic
08/28
08/30
Braschinsky, Mark
CandMig-3, NCT04574713: Candesartan for Migraine Prevention:

Active, not recruiting
2
450
Europe
Candesartan Oral Tablet 8 mg, Candesartan Oral Tablet 16 mg, Placebo oral tablet
St. Olavs Hospital, Norwegian University of Science and Technology, Nordlandssykehuset HF, Molde Hospital, Haukeland University Hospital, Sorlandet Hospital HF, University Hospital, Akershus, Ullevaal University Hospital, Rikshospitalet University Hospital, University Hospital of North Norway, Tartu University Hospital
Migraine
04/24
10/24
Migrevention, NCT05458817: Digital-technology Based Interventions on Treatment of Migraine.

Recruiting
N/A
600
Europe
digital platform
Tartu University Hospital, University of Tartu
Migraine, Primary Headache Disorders
01/25
05/25

Download Options